OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
ACE-III (Cognitive Examination)AIMS (Tardive Dyskinesia)ASRM (Altman Mania Scale)ASRS-v1.1 (Adult ADHD Screen)ASSIST (WHO Substance Screen)AUDIT (Alcohol Use Disorders)AUDIT-C (Alcohol Screen)BARS (Akathisia)BDI-II (Beck Depression)BPRS (Brief Psychiatric Rating)BSDS (Bipolar Spectrum Screen)C-SSRS (Suicide Severity)CAGE QuestionnaireCAPS-5 (PTSD Clinical Interview)CDR (Dementia Staging)CDSS (Schizophrenia Depression)CIWA-Ar (Alcohol Withdrawal)COWS (Opioid Withdrawal)Clozapine Safety (REMS)DAST-10 (Drug Abuse Screen)DES-II (Dissociation Scale)EDE-Q (Eating Disorder Severity)EPDS (Postnatal Depression)Epworth Sleepiness ScaleFAST (Alzheimer's Staging)Fagerstrom (Nicotine Dependence)GAD-2 (Anxiety Screen)GAD-7 (Anxiety Severity)GAF (Global Functioning)HAM-D 17 (Hamilton Depression)HCL-32 (Hypomania Checklist)IES-R (Trauma Impact)ISI (Insomnia Severity)LSAS (Social Anxiety)MADRS (Depression Rating)MARSIPAN (Medical Risk in AN)MDQ (Bipolar Screen)MSI-BPD (Borderline PD Screen)Manchester Self-Harm RuleMetabolic Syndrome (Psych)MoCA (Cognitive Assessment)OCI-R (OCD Screen)PANSS (Schizophrenia Severity)PCL-5 (PTSD Checklist DSM-5)PHQ Panic ModulePHQ-2 (Depression Screen)PHQ-9 (Depression Severity)PSP (Personal/Social Performance)PSQI (Pittsburgh Sleep Quality)QTc Prolongation (Psychiatry)SAD PERSONS ScaleSAFE-T ProtocolSBQ-R (Suicidal Behaviors)SCOFF (Eating Disorder Screen)SPIN (Social Phobia)Simpson-Angus Scale (EPS)Y-BOCS (OCD Severity)YMRS (Mania Severity)

Clinical Evidence and Methodology

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • Primary care first-step screening for major depressive disorder (MDD)
  • Annual depression screen in all adults per USPSTF Grade B recommendation
  • Pre-screening before full PHQ-9 to reduce clinician burden
  • Screening in obstetric, oncology, cardiology, and geriatric settings where depression prevalence is elevated

Do Not Use Alone For

  • Confirming a diagnosis of MDD — PHQ-2 positive requires full PHQ-9
  • Severity assessment or monitoring treatment response
  • Screening for dysthymia, bipolar disorder, or anxiety disorders
CLINICAL INSIGHT

How it Works

Scoring

Items

  • Item 1: Little interest or pleasure in doing things (anhedonia)
  • Item 2: Feeling down, depressed, or hopeless (dysphoria)
CLINICAL INSIGHT

Practical Pearls

Performance Characteristics

ThresholdSensitivitySpecificity
≥ 2~83%~78%
≥ 3 (recommended)~79%~86%

Gotchas

  • A score of 0 does NOT rule out depression in high-risk groups (e.g., masked depression in older adults)
  • PHQ-2 does not assess suicidal ideation — always ask directly if clinical concern exists
  • PHQ-2 items are also the first 2 items of PHQ-9; a positive PHQ-2 seamlessly transitions to PHQ-9 completion
CLINICAL INSIGHT

Next Steps

Action by Score

ScoreAction
0–2Negative screen. Rescreen annually or with clinical change.
3–6Positive screen. Complete full PHQ-9 in same encounter.
CLINICAL INSIGHT

Background

Development

PHQ-2 (Depression Screen)

PHQ-2: First-step depression screen. A score ≥ 3 warrants full PHQ-9 assessment. Does not replace clinical judgement.

Over the last 2 weeks, how often have you been bothered by:

1. Little interest or pleasure in doing things?

2. Feeling down, depressed, or hopeless?

No clinical reference data available.